Skip to main content
. Author manuscript; available in PMC: 2012 Mar 10.
Published in final edited form as: Neuroscience. 2010 Dec 24;176:237–253. doi: 10.1016/j.neuroscience.2010.12.031

Fig 10.

Fig 10

(A) TrkA levels measured by Western Blot in brain lysates derived from rats that had completed the 1.00 mg/kg alternate day regimen of DFP plus the two-week washout period. A. Representative blot illustrating a molecular weight marker and TrkA (~140 kDa). B. Blots illustrating TrkA and β-actin (~38-40 kDa) in the same samples from basal forebrain (BF), hippocampus (HIPP), and prefrontal cortex (PFC). C. Data presented in the bar graphs were obtained from densitometry measurements of the bands for TrkA and β-actin and the represent the mean ± SEM for the ratio. * and ** indicates significant difference compared to vehicle-treated control rats, p<0.05, p<0.01 (respectively), two-tailed Student’s t-tests. N = 5-6.